ASPI — ASP Isotopes Inc. Common Stock stock price, charts and financials

Latest market price

4.29

+0.15+3.62%

Overview Short InterestFilings

ASPIQT14ASP Isotopes Inc. Common Stock·NASDAQ

Overview Short InterestFilings

4.29+3.62%

Filing

Up 3.6% — Filed an 8-K material-event report (2026-08-04) — details in the filing.

Medium confidence

Loading chart...

Signal & projected range

Short-squeeze setupHistorical pattern — not a prediction

Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)

Horizon

Unlock the projected rangeSee where this setup landed historically — with Premium.

Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →

VHI+1.93%$13.70 LXU-0.10%$9.81 WLKP+0.14%$21.30 BAK-1.72%$2.28 TROX+4.21%$5.94 GPRE+2.34%$17.03 REX+3.01%$44.44 HUN+4.09%$10.43

Snapshot

Index	-	P/E	-	EPS (ttm)	-2.08	Insider Own	39.44%	Shs Outstand	83.10M	Perf Week	13.49%

Market Cap	356.49M	Forward P/E	-	EPS next Y	-0.32	Insider Trans	-2.34%	Shs Float	67.11M	Perf Month	-22.42%

Enterprise Value	326.49M	PEG	-	EPS next Q	-	Inst Own	-	Short Float	36.11%	Perf Quarter	-16.86%

Income	-174.00M	P/S	13.20	EPS this Y	77.40%	Inst Trans	-	Short Ratio	4.92	Perf Half Y	-28.97%

Sales	27.00M	P/B	1.19	EPS next Y	31.91%	ROA	-29.53%	Short Interest	24.24M	Perf YTD	-19.81%

Book/sh	3.60	P/C	1.23	EPS next 5Y	-	ROE	-117.16%	52W High	14.49 -70.39%	Perf Year	-51.96%

Cash/sh	3.50	P/FCF	-	EPS past 3/5Y	-	ROIC	-12.97%	52W Low	3.51 22.22%	Perf 3Y	254.55%

Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-	Gross Margin	17.62%	Volatility	9.33% 7.78%	Perf 5Y	-

Dividend TTM	-	EV/Sales	12.09	EPS Y/Y TTM	-230.16%	Oper. Margin	-275.28%	ATR (14)	0.41	Perf 10Y	-

Dividend Ex-Date	-	Quick Ratio	4.37	Sales Y/Y TTM	575.00%	Profit Margin	-644.41%	RSI (14)	44.32	Recom	2.00

Dividend Gr. 3/5Y	-	Current Ratio	4.39	EPS Q/Q	50.00%	SMA20	1.27%	Beta	3.61	Target Price	9.50

Payout	0.00%	Debt/Eq	0.83	Sales Q/Q	300.00%	SMA50	-24.88%	Rel Volume	1.16	Prev Close	4.14

Employees	271	LT Debt/Eq	0.77	Earnings	Aug 14	SMA200	-30.15%	Avg Volume	5.04M	Price	4.29

IPO Date	Nov 10, 2022	Option/Short	Yes / Yes	EPS/Sales Surpr.	0.00% -5.57%	Net Debt/EBITDA	-0.32	Volume	5,867,208	Change	3.62%

Analyst Ratings

Date	Action	Analyst	Rating	Target
Dec-04-25	Initiated	Cantor Fitzgerald	Overweight	$13
Oct-27-25	Reiterated	Loop Capital Markets		$15
Oct-04-24	Initiated	Canaccord	Buy	$4.50
Apr-17-24	Reiterated	HC Wainwright & Co.	Buy	$5.50

Latest News

Aug-04-26

Aug-04-2608:01AM

Aeternum Health Announces Change in Strategy, New Management, and Updates Investors on Progressprismmediawire.com

08:00AM

ASP Isotopes Issues Letter to Shareholdersglobenewswire.com

Jul-30-26

Jul-30-2608:00AM

ASP Isotopes to Participate in Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026globenewswire.com

Jul-28-26

Jul-28-2608:00AM

ASP Isotopes to Hold Capital Markets Day on September 8globenewswire.com

Jul-21-26

Jul-21-2610:53PM

ASP Isotopes Inc. (ASPI) Discusses Noble Africa's Merger Plans and Strategy to Become a Publicly Traded Helium Platform Transcriptseekingalpha.com

06:05PM

ASP Isotopes Maps Noble Africa Listing as Helium Project Nears Productionmarketbeat.com

08:00AM

ASP Isotopes Announces Quantum Leap Energy Research Agreement with Texas A&M Engineering Experiment Station to Advance Uranium Conversion Technologyglobenewswire.com

Jul-17-26

Jul-17-2608:00AM

Join the Live Investor Webinar for Noble Africa, the Proposed ASP Isotopes Spin-Out Creating a Public Helium Companyaccessnewswire.com

Jul-16-26

Jul-16-2605:05PM

ASP Isotopes Files Prospectus Related To Offer & Sale By Selling Stockholders Of 23.2M Shares Of Common StockBenzinga

Jul-15-26

Jul-15-2605:58PM

ASP Isotopes Announces Agreements to Exchange Certain QLE Convertible Notes for ASPI Common Stockglobenewswire.com

Jun-25-26

Jun-25-2609:37AM

ASP Isotopes' Subsidiary Noble Africa To Merge With ENDRA Life Sciences Subsidiary; Combined Entity Anticipated To Trade On Nasdaq Under NOBA Ticker; Noble Africa Commences ~$50M Private PlacementBenzinga

Jun-23-26

Jun-23-2608:06AM

ASP Isotopes Subsidiary Tetra4 Enters First Liquid Helium Sales Contract For Production From The Virginia Gas Project In South AfricaBenzinga

Company

ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters in Boca Raton, Florida.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 12/31/2025	FY 2024 12/31/2024	FY 2023 12/31/2023	FY 2022 12/31/2022	FY 2021 12/31/2021	FY 2019 12/31/2019
Total Revenue	27	24	4	0	0	0	23
Cost of Goods Sold Incl. D&A	23	20	3	0	0	0	12
Gross Profit	5	3	2	0	0	0	11
Selling, General and Administrative Excl. Other	63	48	25	15	4	3	7
Research and Development	16	12	3	1	1	0	0
Other Operating Expense	0	1	0	0	0	0	14
Operating Income	-74	-57	-26	-16	-5	-3	-10
Interest Expense	2	1	0	0	0	0	0
Unusual Expense	—	—	—	—	—	—	—
Non-Operating Income (Expense)	-102	-102	-6	0	0	0	0
Net Income Before Taxes	-178	-160	-32	-16	-5	-3	-10
Income Taxes	0	0	0	0	0	0	0
Consolidated Net Income	-174	-175	-32	-16	-5	-3	-10
Net Income From Continuing Operations	-178	-160	-32	-16	-5	-3	-10
Net Income	-174	-175	-32	-16	-5	-3	-10
EPS (Recurring)	-2.08	-2.11	-0.63	-0.49	-0.13	-0.08	-0.30
EPS (Basic, Before Extraordinaries)	-2.08	-2.11	-0.63	-0.49	-0.13	-0.08	-0.30
EPS (Diluted)	-2.08	-2.11	-0.63	-0.49	-0.13	-0.08	-0.30
EBITDA	-170	-157	-32	-16	-5	-3	4
Other After Tax Adjustments	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—
Price To Earnings Ratio	—	—	—	—	—	—	—
Price To Sales Ratio	19.23	18.50	63.42	—	—	—	—
Gross Margin	18.52	12.50	50.00	—	—	—	47.83
Operating Margin	-274.07	-237.50	-650.00	—	—	—	-43.48
Net Margin	-644.44	-729.17	-800.00	—	—	—	-43.48
Shares Outstanding	121	83	56	33	36	34	34
Market Capitalization	519	444	254	59	57	—	—
Operating Lease Expense	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Unlock with Premium

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kiessling Heather	Chief Financial Officer	Jul 01 '26	Sale	6.28	23,124	145,219	1,526,252	Jul 02
Ainscow Donald George	EVP, Gen Counsel, Secretary	Jun 30 '26	Sale	6.14	100,000	614,000	800,000	Jul 02
Wider Todd	Director	Jun 30 '26	Sale	6.12	50,000	306,000	672,247	Jul 01
Gorley Michael	Director	Jun 30 '26	Sale	6.27	30,000	188,100	87,908	Jul 01
Wider Todd	Director	Jun 29 '26	Sale	6.25	50,000	312,500	722,247	Jul 01
Ainscow Robert	COO	Jun 08 '26	Sale	7.00	8,438	59,058	2,281,879	Jun 10
Mann Paul Elliot	Chairman and CEO	Jun 03 '26	Sale	7.76	83,759	649,970	9,579,845	Jun 03
Mann Paul Elliot	Chairman and CEO	Jun 02 '26	Sale	8.29	83,758	694,354	9,663,424	Jun 03
Mann Paul Elliot	Chairman and CEO	Jun 01 '26	Sale	7.88	83,758	660,013	9,747,182	Jun 03
Ainscow Robert	COO	Apr 16 '26	Sale	5.21	22,500	117,113	1,490,317	Apr 17
Moore Duncan	Director	Apr 16 '26	Sale	5.21	11,642	60,597	1,044,928	Apr 17
Kiessling Heather	Chief Financial Officer	Apr 15 '26	Sale	5.48	23,124	126,673	709,376	Apr 17
Ainscow Robert	COO	Mar 06 '26	Sale	4.75	33,438	158,669	1,512,817	Apr 13
Mann Paul Elliot	Executive Chairman	Mar 02 '26	Sale	5.44	162,153	881,464	7,597,385	Mar 02
Kiessling Heather	Chief Financial Officer	Dec 18 '25	Sale	5.80	80,000	463,840	732,500	Dec 29

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.